These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

776 related articles for article (PubMed ID: 7997877)

  • 21. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
    Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
    Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in cyclins and cyclin-dependent kinases induced by DNA damaging agents in a human ovarian cancer cell line expressing mutated or wild-type P53.
    Vikhanskaya F; Erba E; D'Incalci M; Broggini M
    Exp Cell Res; 1996 Sep; 227(2):380-5. PubMed ID: 8831577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations.
    Delia D; Goi K; Mizutani S; Yamada T; Aiello A; Fontanella E; Lamorte G; Iwata S; Ishioka C; Krajewski S; Reed JC; Pierotti MA
    Oncogene; 1997 May; 14(18):2137-47. PubMed ID: 9174049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cell cycle control, genetic instability and cancer].
    Funk JO; Kind P
    Hautarzt; 1997 Mar; 48(3):157-65. PubMed ID: 9182085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell cycle checkpoint control mechanisms that can be disrupted in cancer.
    Dash BC; El-Deiry WS
    Methods Mol Biol; 2004; 280():99-161. PubMed ID: 15187251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Checkpoint controls and cancer. Introduction.
    Kastan MB
    Cancer Surv; 1997; 29():1-6. PubMed ID: 9338093
    [No Abstract]   [Full Text] [Related]  

  • 27. Mechanisms of cell-cycle checkpoints: at the crossroads of carcinogenesis and drug discovery.
    Flatt PM; Pietenpol JA
    Drug Metab Rev; 2000; 32(3-4):283-305. PubMed ID: 11139130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular foundations of cancer: new targets for intervention.
    Karp JE; Broder S
    Nat Med; 1995 Apr; 1(4):309-20. PubMed ID: 7585060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Regulation of cell cycle checkpoints in mammalian cells].
    Nakanishi M
    Seikagaku; 2001 May; 73(5):343-50. PubMed ID: 11452440
    [No Abstract]   [Full Text] [Related]  

  • 30. The molecular and cellular basis of radiosensitivity: implications for understanding how normal tissues and tumors respond to therapeutic radiation.
    Rosen EM; Fan S; Rockwell S; Goldberg ID
    Cancer Invest; 1999; 17(1):56-72. PubMed ID: 10999050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
    Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
    Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of Wild-Type p53 Signaling in Suppressing Apoptosis in Response to Chemical Genotoxic Agents: Impact on Chemotherapy Outcome.
    Mirzayans R; Andrais B; Kumar P; Murray D
    Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28452953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the chemosensitivity of head and neck cancer cells based on the diverse function of mutated-p53.
    Shinagawa Y; Kawamata H; Omotehara F; Nakashiro K; Hoque MO; Furihata T; Horiuchi H; Imai Y; Fujimori T; Fujibayashi T
    Int J Oncol; 2003 Feb; 22(2):383-9. PubMed ID: 12527938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell cycle checkpoints: the role and evaluation for early diagnosis of senescence, cardiovascular, cancer, and neurodegenerative diseases.
    Golubnitschaja O
    Amino Acids; 2007; 32(3):359-71. PubMed ID: 17136506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiation-induced phosphorylation of Chk1 at S345 is associated with p53-dependent cell cycle arrest pathways.
    Tian H; Faje AT; Lee SL; Jorgensen TJ
    Neoplasia; 2002; 4(2):171-80. PubMed ID: 11896572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro transcriptional activation of p21 promoter by p53.
    Kim TK
    Biochem Biophys Res Commun; 1997 May; 234(2):300-2. PubMed ID: 9177263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation.
    Malashicheva AB; Kislyakova TV; Aksenov ND; Osipov KA; Pospelov VA
    Oncogene; 2000 Aug; 19(34):3858-65. PubMed ID: 10951579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Pezcoller lecture: cancer cell cycles revisited.
    Sherr CJ
    Cancer Res; 2000 Jul; 60(14):3689-95. PubMed ID: 10919634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Principles of tumor suppression.
    Sherr CJ
    Cell; 2004 Jan; 116(2):235-46. PubMed ID: 14744434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induced genome maintenance pathways in pre-cancer tissues describe an anti-cancer barrier in tumor development.
    Simão ÉM; Sinigaglia M; Bugs CA; Castro MA; Librelotto GR; Alves R; Mombach JC
    Mol Biosyst; 2012 Nov; 8(11):3003-9. PubMed ID: 22955060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.